Pancreatobiliary-type intraductal papillary mucinous neoplasm of the pancreas may have two subtypes with distinct clinicopathological and genetic features.

[1]  Seung‐Mo Hong,et al.  IL‐33 overexpression in gallbladder cancers associated with pancreatobiliary maljunction , 2019, Histopathology.

[2]  Y. Zen,et al.  Intracholecystic Papillary Neoplasms Are Distinct From Papillary Gallbladder Cancers: A Clinicopathologic and Exome-sequencing Study , 2019, The American journal of surgical pathology.

[3]  Y. Zen,et al.  CT imaging comparison between intraductal papillary neoplasms of the bile duct and papillary cholangiocarcinomas , 2018, European Radiology.

[4]  Y. Zen,et al.  Recurrent Mutations in APC and CTNNB1 and Activated Wnt/&bgr;-catenin Signaling in Intraductal Papillary Neoplasms of the Bile Duct: A Whole Exome Sequencing Study , 2018, The American journal of surgical pathology.

[5]  Seung‐Mo Hong,et al.  High‐grade PanIN presenting with localised stricture of the main pancreatic duct: A clinicopathological and molecular study of 10 cases suggests a clue for the early detection of pancreatic cancer , 2018, Histopathology.

[6]  Y. Zen,et al.  Mucinous cystic neoplasms of the liver and pancreas: relationship between KRAS driver mutations and disease progression , 2017, Histopathology.

[7]  S. Monaco,et al.  Preoperative next-generation sequencing of pancreatic cyst fluid is highly accurate in cyst classification and detection of advanced neoplasia , 2017, Gut.

[8]  M. Del Chiaro,et al.  Intraductal papillary mucinous neoplasms of the pancreas: reporting clinically relevant features , 2017, Histopathology.

[9]  Y. Ku,et al.  Comparative clinicopathological study of biliary intraductal papillary neoplasms and papillary cholangiocarcinomas , 2016, Histopathology.

[10]  Jérôme Alexandre Denis,et al.  Droplet digital PCR of circulating tumor cells from colorectal cancer patients can predict KRAS mutations before surgery , 2016, Molecular oncology.

[11]  A. Krasinskas,et al.  A Revised Classification System and Recommendations From the Baltimore Consensus Meeting for Neoplastic Precursor Lesions in the Pancreas , 2015, The American journal of surgical pathology.

[12]  Y. Yatabe,et al.  GNAS mutation is a frequent event in pancreatic intraductal papillary mucinous neoplasms and associated adenocarcinomas , 2015, Virchows Archiv.

[13]  Masakazu Yamamoto,et al.  Molecular Biomarkers for Progression of Intraductal Papillary Mucinous Neoplasm of the Pancreas , 2015, Pancreas.

[14]  O. Basturk,et al.  Intraductal neoplasms of the pancreas. , 2014, Seminars in diagnostic pathology.

[15]  Rita T Lawlor,et al.  Targeted next-generation sequencing of cancer genes dissects the molecular profiles of intraductal papillary neoplasms of the pancreas , 2014, The Journal of pathology.

[16]  G. Kristiansen,et al.  GNAS Sequencing Identifies IPMN-specific Mutations in a Subgroup of Diminutive Pancreatic Cysts Referred to as “Incipient IPMNs” , 2014, The American journal of surgical pathology.

[17]  N. Sainani,et al.  Cystic Papillary Pattern in Pancreatic Ductal Adenocarcinoma: A Heretofore Undescribed Morphologic Pattern That Mimics Intraductal Papillary Mucinous Carcinoma , 2012, The American journal of surgical pathology.

[18]  Masakazu Yamamoto,et al.  Whole-exome sequencing uncovers frequent GNAS mutations in intraductal papillary mucinous neoplasms of the pancreas , 2011, Scientific reports.

[19]  Y. Kakeji,et al.  Nuclear atypia grading score is a useful prognostic factor in papillary gastric adenocarcinoma , 2011, Histopathology.

[20]  A. Maitra,et al.  Recurrent GNAS Mutations Define an Unexpected Pathway for Pancreatic Cyst Development , 2011, Science Translational Medicine.

[21]  R. Hruban,et al.  Classification of types of intraductal papillary-mucinous neoplasm of the pancreas: a consensus study , 2005, Virchows Archiv.

[22]  R. Start.  AFIP Atlas of Tumor Pathology , 2000 .

[23]  A. Sparks,et al.  Immunohistochemical labeling for dpc4 mirrors genetic status in pancreatic adenocarcinomas : a new marker of DPC4 inactivation. , 2000, The American journal of pathology.